Stock Ratings / Health Care / TAK / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Takeda Pharmaceutical Company Limited American (TAK) 12-Month Stock Forecast & Price Target Cone

$20.01 -0.69% NYSE • Public Delayed / 60s Snapshot

Takeda Pharmaceutical Company Limited American (TAK) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C • HOLD / WATCH Cap $63.23B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+3.1% Base Target

WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($6.3M)

44% PutsMax Pain: $20.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your TAK Position Size: $10,000

Shares at $20.01: 499.8 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $16.10

$8,046

$-1,954 (-19.5%)

12M Consensus BaseTarget $20.64

$10,315

+$315 (+3.1%)

12M Bull Case BreakoutTarget $24.36

$12,174

+$2,174 (+21.7%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$21	74%	A
Goldman SachsSector Coverage Lead	BUY	$23	69%	B
JP MorganUS Large-Cap Research	HOLD	$18	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live TAK Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

TAK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +25.36%▲ RESISTANCE BREAKOUT

2026-10-30O $21.00H $21.22L $20.79C $20.91VOL 4.62M

RES: $20.77SUP: $18.36SMA50: $18.84SMA200: $17.55

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TAK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TAK Butterfly Map → + Track TAK →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.3%/yr Implied 5Y Growth

vs. -3.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TAK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TAK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TAK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

TAK Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is TAK's 12-month stock price target?

Takeda Pharmaceutical Company Limited American (TAK) carries a 12-month consensus base price target of $20.64 (+3.1% from $20.01), with a bull-case target of $24.36 and a bear-case floor of $16.1.

Is TAK stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates TAK C (Hold — HOLD) with an RQD Confidence score of 65/100.

Direct Sub-Reports: TAK RQD Cockpit TAK 12M Forecast TAK Earnings & Move TAK Dividends & DRIP TAK Insiders & 13F TAK Whale Options TAK Profit Sankey TAK News & Why